Real World Canadian Case Series: Use of Tildrakizumab for Moderate to Severe Psoriasis Frontiers Promising strategies in natural products treatments of psoriasis update Many treatment guidelines for psoriasis rely heavily on body surface area (BSA) involvement to determine disease severity and eligibility for systemic therapies like biologics. Traditionally, patients with less than 10% BSA involvementespecially Peptides Lack Reliable Safety Information, Watchdog Warns